Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer
Enzinger, P. C., Ryan, D. P., Clark, J. W., Muzikansky, A., Earle, C. C., Kulke, M. H., Meyerhardt, J. A., Blaszkowsky, L. S., Zhu, A. X., Fidias, P., Vincitore, M. M., Mayer, R. J., Fuchs, C. S.Volume:
20
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdn658
Date:
October, 2008
File:
PDF, 92 KB
english, 2008